(Q34981791)

5 August 2017

title

A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine (English)

1 reference

multicenter clinical trial

5 August 2017

main subject

0 references

0 references

1 reference

Filippo Brighina

1 reference

5 August 2017

Paolo Martelletti

1 reference

5 August 2017

Michel D Ferrari

1 reference

5 August 2017

Marco Bartolini

1 reference

5 August 2017

Maria Adele Giamberardino

1 reference

5 August 2017

Carlo Lisotto

1 reference

5 August 2017

Davide Moscato

1 reference

5 August 2017

Biagio Panascia

1 reference

5 August 2017

Lidia Savi

1 reference

5 August 2017

Luigi Alberto Pini

1 reference

5 August 2017

Grazia Sances

1 reference

5 August 2017

Patrizia Santoro

1 reference

5 August 2017

Giorgio Zanchin

1 reference

5 August 2017

Stefano Omboni

1 reference

5 August 2017

Brigida Fierro

1 reference

5 August 2017

publication date

25 March 2011

1 reference

The journal of headache and pain : official journal of the Italian Society for the Study of Headaches

5 August 2017

published in

1 reference

5 August 2017

1 reference

5 August 2017

1 reference

5 August 2017

page(s)

361-368

1 reference

Creative Commons Attribution 2.0 Generic

5 August 2017

start time

25 March 2011

1 reference

April 2022 Public Data File from Crossref

copyrighted

0 references

cites work

Triptans for the management of migraine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094646

A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094646

Triptan therapy in migraine

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094646

Migraine update. Diagnosis and treatment

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094646

Frovatriptan versus zolmitriptan for the acute treatment of migraine: a double-blind, randomized, multicenter, Italian study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094646

Almotriptan for the treatment of acute migraine: a review of early intervention trials

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094646

Frovatriptan in the practice of office-based neurologists/pain therapists: Results of postmarketing surveillance study ALADIN.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094646

Clinical and economic comparison of frovatriptan versus other oral triptans in the treatment of acute migraine in the real-world setting

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094646

Rapid responders to frovatriptan in acute migraine treatment: results from a long-term, open-label study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094646

Review of frovatriptan in the treatment of migraine

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094646

Frovatriptan: a review of pharmacology, pharmacokinetics and clinical potential in the treatment of menstrual migraine

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094646

Almotriptan: meeting today's needs in acute migraine treatment

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094646

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094646

Sumatriptan: update and review

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094646

Efficacy and tolerability of frovatriptan in acute migraine treatment: systematic review of randomized controlled trials

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094646

Randomized, placebo-controlled comparison of early use of frovatriptan in a migraine attack versus dosing after the headache has become moderate or severe

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094646

Frovatriptan succinate, a 5-HT1B/1D receptor agonist for migraine

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094646

The International Classification of Headache Disorders: 2nd edition

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094646

Meta-analysis of oral triptan therapy for migraine: number needed to treat and relative cost to achieve relief within 2 hours

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094646

Migraine headache recurrence: relationship to clinical, pharmacological, and pharmacokinetic properties of triptans

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094646

Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094646

Frovatriptan: a review of drug-drug interactions

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094646

Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094646

Postmarketing migraine survey of frovatriptan: effectiveness and tolerability vs previous triptans, NSAIDs or a combination

8 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10194-011-0325-5

Treatment response and tolerability of frovatriptan in patients reporting short- or long-duration migraines at baseline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10194-011-0325-5

Tolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10194-011-0325-5

Assessing patient preference in migraine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10194-011-0325-5

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/21437714

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S10194-011-0325-5

1 reference

Dimensions Publication ID

5 August 2017

0 references

1 reference

5 August 2017

1 reference